Latest Breaking News On - Mike clayman - Page 1 : comparemela.com
Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Best CEOs of Small and Midsize Companies, Ranked by Female Employees
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
Operator
Good afternoon, ladies and gentlemen. And welcome to the Flexion Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] We will be facilitating a question-and-answer session at the end of today s call. [Operator Instructions]
I ll now turn the call over to Scott Young, Flexion s Vice President of Corporate Communications and Investor Relations.
Scott Young
Vice President of Corporate Communications & Investor Relations
Good afternoon. A short while ago, we issued a press release announcing our Q1 2021 financial results. In addition, today, we are introducing refreshed metrics to provide increased visibility and insights into the commercial performance of ZILRETTA. Our earnings press release and the commercial metrics slide can be found under the Investors tab on the company s website and a replay of this call will be accessible there shortly after its conclusion.
Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
Flexion Therapeutics Inc (NASDAQ: FLXN)
Popular Searches
Operator
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Business Update Call. [Operator Instructions]
I will now turn the call over to Scott Young, Flexion s Vice President of Corporate Communications and Investor Relations.SPONSORED:
10 stocks we like better than Flexion Therapeutics
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market.
Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.